Company Data
Viridian Therapeutics Inc.
Ticker
VRDN
Current Price
$16.35 3.02%
Market Cap
$1.7B
Price Target
Refer to Report
Volume
1.7M
52wk Range
$13.18 - $34.29
Overview
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.